Zhongchao Operating Margin 2019-2024 | ZCMD
Current and historical operating margin for Zhongchao (ZCMD) over the last 10 years. The current operating profit margin for Zhongchao as of June 30, 2024 is 0.00%.
| Zhongchao Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.033B | $0.016B |
| Zhongchao Inc. is a provider of healthcare information, professional training and educational services to healthcare professionals under its MDMOOC platform and to the public under its Sunshine Health Forums platform. Zhongchao Inc. is headquartered in Beijing, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.877B | 52.32 |
| Hims & Hers Health (HIMS) | United States | $10.991B | 115.05 |
| Tempus AI (TEM) | United States | $8.988B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.774B | 74.60 |
| IRhythm Technologies (IRTC) | United States | $4.316B | 0.00 |
| Privia Health (PRVA) | United States | $2.756B | 206.54 |
| Enovis (ENOV) | United States | $1.947B | 12.05 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.712B | 0.00 |
| Phreesia (PHR) | United States | $1.426B | 0.00 |
| Omnicell (OMCL) | United States | $1.202B | 21.21 |
| Azenta (AZTA) | United States | $1.162B | 54.08 |
| 10x Genomics (TXG) | United States | $0.991B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.573B | 0.00 |
| Talkspace (TALK) | United States | $0.530B | 157.25 |
| Butterfly Network (BFLY) | United States | $0.527B | 0.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 0.00 |
| Claritev (CTEV) | United States | $0.329B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.218B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.095B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.45 |
| MDxHealth SA (MDXH) | Belgium | $0.080B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |